Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by iplaygolfon Dec 15, 2017 5:15pm
31 Views
Post# 27168609

RE:RE:RE:RE:RE:Who ignored me? Lord of the flies much....

RE:RE:RE:RE:RE:Who ignored me? Lord of the flies much....My concerns regard managements past but I give second chances.  If HOPS CBD pans out and they can Be in pharmacies world wide and potentially Be the only company to do so then this is much bigger than one quarter after legalization.   I’ll hold for ten years once they become the leader in the future of pharmaceuticals.   JNJ 353$ a share.  Isol products could be on every shelf in every category of products.  So that’s enough for me to hold. Red days don’t scare me for that potential.   Even if goes back to 1$ or less   This is a long term play.  Won’t be scared out of short term shares 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities